Solventum will host a conference call today, Nov. 6, at 4:30 p.m. Eastern Time to discuss its third quarter financial results and provide an update on its business. The conference call can be accessed ...

Solventum (SOLV) has been in focus among investors as the stock showed some movement over the past week, catching attention because of changes in its recent performance and valuation. See our latest ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

17/12 Solventum publie les recommandations d'un panel international et multidisciplinaire d'experts en chirurgie et en soins des plaies sur l'utilisation clinique de la thérapie par pression négative ...

On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...

20/11 Solventum acquiert Acera Surgical et lance un programme de rachat d'actions d'un milliard de dollars MT 20/11 Solventum annonce un accord pour l'acquisition d'Acera Surgical RE 20/11 Solventum ...

Solventum Corporation, a healthcare spin-off from 3M Company, had a soft start of trading due to flattish sales and high debt. The company operates in various healthcare segments, including MedSurg, ...